1352546-95-2

Basic information

• Product Name: 2-(4-hydroxyphenyl)-1-(4-((S)-2-((R)-3-methylpyrrolidin-1-yl)propoxy)phenyl)-2,3-dihydro-1H-inden-5-ol
• Synonyms: 2-(4-hydroxyphenyl)-1-(4-((S)-2-((R)-3-methylpyrrolidin-1-yl)propoxy)phenyl)-2,3-dihydro-1H-inden-5-ol
• CAS NO: 1352546-95-2
• Molecular Weight: 443.586
• Mol File: 1352546-95-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-(4-hydroxyphenyl)-1-(4-((S)-2-((R)-3-methylpyrrolidin-1-yl)propoxy)phenyl)-2,3-dihydro-1H-inden-5-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-hydroxyphenyl)-1-(4-((S)-2-((R)-3-methylpyrrolidin-1-yl)propoxy)phenyl)-2,3-dihydro-1H-inden-5-ol(1352546-95-2)
• EPA Substance Registry System: 2-(4-hydroxyphenyl)-1-(4-((S)-2-((R)-3-methylpyrrolidin-1-yl)propoxy)phenyl)-2,3-dihydro-1H-inden-5-ol(1352546-95-2)

Safety Data

• Hazardous Substances Data: 1352546-95-2(Hazardous Substances Data)

Upstream product

• 1096920-35-2 1-(4-iodophenyl)-2-(4-methoxyphenyl)ethan-1-one 
• 1352547-08-0 (3R)-1-((2S)-1-(4-(5-methoxy-2-(4-methoxyphenyl)-2,3-dihydro-1H-inden-1-yl)phenoxy)propan-2-yl)-3-methylpyrrolidine 
• 1352547-07-9 (R)-1-((S)-1-(4-(6-methoxy-2-(4-methoxyphenyl)-1H-inden-3-yl)phenoxy)propan-2-yl)-3-methylpyrrolidine 
• 2938-98-9 (R)-2-methylbutane-1,4-diol 
• 1352547-04-6 3-(4-iodophenyl)-6-methoxy-2-(4-methoxyphenyl)-1H-indene 
• 1352547-01-3 1-(4-iodophenyl)-3-(3-methoxyphenyl)-2-(4-methoxyphenyl)propan-1-one 
• 620627-27-2 (S)-2-((R)-3-methylpyrrolidin-1-yl)propan-1-ol 
• 22644-27-5 (R)-methylsuccinic acid dimethyl ester 
• 187617-01-2 N,O-Dimethyl-4-iodobenzenehydroxamic acid 
• 1711-02-0 4-iodobenzoic acid chloride 
• 824-98-6 m-methoxybenzyl chloride 

Relevant articles and documents

INDANE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.